BRAVE 发表于 2025-3-25 06:54:34

http://reply.papertrans.cn/1/9/832/832-21.png

提名的名单 发表于 2025-3-25 11:19:57

Submitted on: 03 November 2009.
Revised on: 01 February 2010.
Accepted on: 01 March 2010.

___________________Advances in Virology---HINDAWI LTD

无法治愈 发表于 2025-3-25 14:52:57

http://reply.papertrans.cn/1/9/832/832-23.png

连接 发表于 2025-3-25 17:09:55

Submitted on: 25 June 2008.
Revised on: 20 September 2008.
Accepted on: 04 November 2008.

___________________Advances in Virology---HINDAWI LTD

Perceive 发表于 2025-3-25 22:35:43

Submitted on: 25 March 2017.
Revised on: 20 May 2017.
Accepted on: 03 June 2017.

___________________Advances in Virology---HINDAWI LTD

灵敏 发表于 2025-3-26 00:39:08

http://reply.papertrans.cn/1/9/832/832-26.png

Cantankerous 发表于 2025-3-26 06:38:00

Submitted on: 10 October 2015.
Revised on: 14 December 2015.
Accepted on: 11 January 2016.

___________________Advances in Virology---HINDAWI LTD

千篇一律 发表于 2025-3-26 10:43:36

http://reply.papertrans.cn/1/9/832/832-28.png

Fallibility 发表于 2025-3-26 14:52:24

http://reply.papertrans.cn/1/9/832/832-29.png

MILK 发表于 2025-3-26 20:45:55

http://reply.papertrans.cn/1/9/832/832-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Advances in Virology 2024/2025影响因子:1.146 (ADV VIROL) (1687-8639). (VIROLOGY)(病毒学)Emerging Sources Citation Index